Status:

COMPLETED

Effects of a Single Oral Dose of KETone Ester ON Exercise Performance in Patients With Chronic Heart Failure

Lead Sponsor:

University Medical Center Groningen

Collaborating Sponsors:

Netherlands Heart Foundation

Conditions:

Heart Failure With Reduced Ejection Fraction

Heart Failure

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

In a randomized, double-blind, placebo-controlled cross-over design, subjects will either receive a supplemental drink containing a commercially available ketone ester (DeltaG®, 500 mg/kg body weight)...

Detailed Description

The goal of this study is to investigate if oral ketone supplementation stimulates mitochondrial ATP production and improves exercise performance in patients with chronic HF. In a randomized, double-b...

Eligibility Criteria

Inclusion

  • Chronic Heart Failure NYHA II - III
  • LVEF ≤40%
  • Stable for the last 1 month prior to the study

Exclusion

  • Age \<18 years;
  • Unable or unwilling to undergo exercise MRI (physical disabilities, claustrophobia);
  • Unable to complete the exercise protocol during the screening visit according to the professional opinion of the investigators;
  • Comorbidities which can influence study results such as muscular dystrophies, peripheral artery disease, diabetes mellitus, severe anaemia (defined as Hb ≤6 mmol/L);
  • Pregnant/trying to get pregnant/breastfeeding during the period from the first exercise test until 4 weeks after the last exercise test);
  • Absolute contra-indications to undergo MRI according to the current UMCG protocols and guidelines (e.g. non-conditional medical device, recent device implantation, incompatible ferromagnetic objects in the body).
  • BMI \< 16 kg/m2; BMI \> 35 kg/m2
  • Unable to understand study procedures;
  • Unable or unwilling to provide informed consent.

Key Trial Info

Start Date :

February 15 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2023

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT05348460

Start Date

February 15 2022

End Date

July 1 2023

Last Update

May 3 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Medical Center Groningen

Groningen, Netherlands, 9713GZ